A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease

NCT03270956 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Chronic Kidney Disease

Interventions

BIOLOGICAL: Renal Autologous Cell Therapy (REACT)

Sponsor

Prokidney

Collaborators

[object Object]